Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge
about
A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsQuantitative real time polymerase chain reaction for measurement of human interleukin-5 receptor alpha spliced isoforms mRNAActivation states of blood eosinophils in asthmaDifferential diagnosis of eosinophilic chronic rhinosinusitisMonoclonal antibodies and other biologic agents in the treatment of asthmaThe peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation.Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthmaEosinophil Activation Status in Separate Compartments and Association with AsthmaHuman airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils.Cholesterol selectively regulates IL-5 induced mitogen activated protein kinase signaling in human eosinophilsIdentification of genes expressed by human airway eosinophils after an in vivo allergen challenge.IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human EosinophilsFunctional activity of peripheral blood eosinophils in allergen-induced late-phase airway inflammation in asthma patients.IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.Biologic therapies targeting eosinophils: current status and future prospects.Defective eosinophil hematopoiesis ex vivo in inbred Rocky Mountain White (IRW) miceCross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation.Cytokine-regulated accumulation of eosinophils in inflammatory disease.Current and future biomarkers in allergic asthma.The rise of the phoenix: the expanding role of the eosinophil in health and disease.Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.A sensitive high throughput ELISA for human eosinophil peroxidase: a specific assay to quantify eosinophil degranulation from patient-derived sources.Anti-interleukin-5 antibody therapy in eosinophilic diseases.Anti-IL-5 attenuates activation and surface density of β(2) -integrins on circulating eosinophils after segmental antigen challenge.The NR4A nuclear receptor family in eosinophils.Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma.Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma.Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge.Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF.Human airway eosinophils exhibit preferential reduction in STAT signaling capacity and increased CISH expression.Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patientsAirway eosinophils: allergic inflammation recruited professional antigen-presenting cells.Role of insulin-like growth factor binding protein-3 in allergic airway remodeling.The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.Increases in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma.CCR3 antagonists: a survey of the patent literature.Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokinesAllergy, asthma, and inflammation: which inflammatory cell type is more important?Asthma: a simple concept but in reality a complex disease.
P2860
Q24647672-AE3E0A5E-E72A-4E26-8488-A536D172EA32Q24792565-8C94BB53-7388-4B6E-B7CA-080DD8D73134Q26853383-AC622FCA-C349-4017-A0A6-0FF8AABD9618Q28196300-3E7ADD3C-4ABA-4076-9E20-E17634704112Q28270037-7A6DCA4C-9111-4F2C-B5A4-685D97820D75Q33762811-4FB35934-F756-4D41-81FD-5CE0DF51F53AQ33775800-253FA8AA-4130-42C7-B181-8A6134311470Q33785627-29C3986D-7E17-4ABA-898D-CC1A1195BC2AQ33982401-512D4A75-0690-4F7C-987C-E103DDD9F599Q34046647-61FE0BB9-F71E-457D-843D-1811B4D70570Q34356793-92A217E2-2FEA-4D5F-BAB5-C7FFFD5A8849Q34489670-FED3AFB5-CC1B-4D63-8CD9-8610E9E3CDEEQ35233749-89A0B2C8-30AE-4004-A830-AD9B4A967BECQ35490676-EBA0D1AB-C157-4AD2-A405-6711BC26622AQ35565533-B3CAF5E2-9D4A-44E9-9D8E-70AF5707161DQ35609388-257F906A-A6C5-41EC-B026-EAAD0DDAD6CEQ35737263-6032B25A-EA5B-4532-A29C-F0FD3A6A2671Q35824797-79A0DE8C-8F3D-4E80-9874-39E0C7723190Q35878914-8E1D488D-548E-4F4E-A0A3-49384418CD68Q35970099-CABDF2B6-66D2-43B5-BD3B-D80C02B68C3DQ36128536-C7E9D711-12DD-4DFE-85CA-42AF2FB2B62BQ36204887-CDBF58BF-A87A-455C-8763-BAB2CB7D4AECQ36438486-9B9FF606-53A0-48B4-944B-0CA6D0BB1A4EQ36630280-59B0E37C-8585-4B7B-B77A-60D415AE4191Q36649696-A9F12490-E58F-4966-B781-586FE4655114Q36757477-21C42C37-F762-45A6-B2AC-0819C126DA57Q36955887-5ED08A27-558A-4785-95F8-D799FD43EF7EQ36980346-1B8AC6BE-DC0A-4526-8728-BCE6BB8B3920Q37098597-D9BC421C-8460-46BF-9573-935D035B4080Q37165737-DA291F16-DBC3-4B3E-BC1A-056B5F37369BQ37206758-6466BA9B-D7B8-4706-9D6F-8A085FC60DD9Q37292431-A2FE0D61-A322-44F8-9D91-FB89A6C14F76Q37327205-E42431E8-8624-4FF8-BFDA-0D1051C58A44Q37366899-5BEDD0DD-FEE0-44CA-B214-3D3B66ACD848Q37505217-738A5F89-02B1-444F-B0DD-FC1053C22E4FQ37505259-818A727C-77D6-446F-BBBB-ACF75FCB1CABQ37564516-4AEB01A7-68DC-4FAA-830A-7D51E5BD67D8Q37625993-EEDEBE9A-D5B9-4466-8881-C8A34CC301FCQ37762862-D224815D-C693-4071-A6C2-D9F35D9EABA2Q37880256-1EC30114-CDAB-43C8-B562-6A6105441EDA
P2860
Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Decreased expression of membra ...... irway after allergen challenge
@ast
Decreased expression of membra ...... irway after allergen challenge
@en
Decreased expression of membra ...... irway after allergen challenge
@nl
type
label
Decreased expression of membra ...... irway after allergen challenge
@ast
Decreased expression of membra ...... irway after allergen challenge
@en
Decreased expression of membra ...... irway after allergen challenge
@nl
altLabel
Decreased Expression of Membra ...... irway After Allergen Challenge
@en
prefLabel
Decreased expression of membra ...... irway after allergen challenge
@ast
Decreased expression of membra ...... irway after allergen challenge
@en
Decreased expression of membra ...... irway after allergen challenge
@nl
P2093
P3181
P1476
Decreased Expression of Membra ...... irway After Allergen Challenge
@en
Decreased expression of membra ...... irway after allergen challenge
@en
P2093
E. A. B. Kelly
Elizabeth A B Kelly
Hirohita Kita
J. B. Sedgwick
J. E. Gern
James E Gern
Julie B Sedgwick
Lin Ying Liu
P3181
P356
10.4049/JIMMUNOL.169.11.6452
P407
P577
2002-12-01T00:00:00Z